Bevacizumab plus irinotecan in recurrent glioblastoma - Reply

被引：4
|
作者：
Vredenburgh, James J. [1 ]
Desjardins, Annick
Reardon, David A.
Friedman, Henry S.
机构：
[1] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 06期
关键词：
D O I：
10.1200/JCO.2007.15.1746
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1013 / 1013
页数：1
相关论文
共 50 条
  • [1] Bevacizumab plus irinotecan in recurrent glioblastoma
    Chamberlain, Marc C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 1012 - 1013
  • [2] Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Marcello, Jennifer
    Reardon, David A.
    Quinn, Jennifer A.
    Rich, Jeremy N.
    Sathornsumetee, Sith
    Gururangan, Sridharan
    Sampson, John
    Wagner, Melissa
    Bailey, Leighann
    Bigner, Darell D.
    Friedman, Allan H.
    Friedman, Henry S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4722 - 4729
  • [3] Irinotecan and bevacizumab in recurrent glioblastoma multiforme
    Jakobsen, Jan Nyrop
    Hasselbalch, Benedikte
    Stockhausen, Marie-Therese
    Lassen, Ulrik
    Poulsen, Hans Skovgaard
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (05) : 825 - 833
  • [4] Letter to the Editor: Commentary on "Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma"
    Tini, Paolo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (41)
  • [5] Second-line treatment of bevacizumab plus lomustine versus bevacizumab plus irinotecan in patients with recurrent glioblastoma
    Simoes, J.
    Tavares, N. T.
    Borges, C.
    Meireles, S.
    Fernandes, C.
    Costa, A.
    Caeiro, C.
    Damasceno, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Flashback Foreword: Bevacizumab and Irinotecan in Recurrent Glioblastoma
    Mellinghoff, Ingo K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (32) : 4943 - +
  • [7] BEVACIZUMAB AND IRINOTECAN IN THE TREATMENT OF PATIENTS WITH RECURRENT GLIOBLASTOMA
    Naskhletashvili, D. R.
    Gorbounova, V.
    Bychkov, M.
    Bekyashev, A.
    Karakhan, V.
    Aloshin, V.
    Fu, R.
    Moskvina, E.
    NEURO-ONCOLOGY, 2012, 14 : 59 - 59
  • [8] Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
    Friedman, Henry S.
    Prados, Michael D.
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Huang, Jane
    Zheng, Maoxia
    Cloughesy, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4733 - 4740
  • [9] BEVACIZUMAB PLUS IRINOTECAN IN RECURRENT GLIOBLASTOMA MULTIFORME - EXPERIENCE IN THE JUAN RAMON JIMENEZ HOSPITAL
    Fernandez, M.
    NEURO-ONCOLOGY, 2012, 14 : 49 - 49
  • [10] Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma: A Nationwide Population-Based Study
    Lee, Yeonhu
    Lee, Eunyoung
    Roh, Tae Hoon
    Kim, Se-Hyuk
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (34)
12345